Clinical implication of organic anion transporters in the proximal tubule
Clinical implication of organic anion transporters in the proximal tubule
批准号:
13671128
负责人:
TAKEDA Michio
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human organic anion transporter (hOAT) and human organic cation transporter (hOCT) play important roles in the tubular secretion of drugs. HOAT1, 2, 3, hOCT2 are localized to the basolateral side of the proximal tubule and mediate the uptake of drugs into the proximal tubule. HOAT4 is localized to the apical side of the proximal tubule and mediates the urinary secretion or the reabsorption of drugs. Using cell lines stably expressing these transporters, we have obtained the results as below. 1. Identification of transporters responsible for drug transport: HOATs and hOCTs responsible for renal drug transport were identified as follows; (1) Prostaglandin E2α F2: hOAT1, 2, 3, 4, hOCT1, 2, (2) Antivirals (Acyclovir and Ganciclovir): hOAT1, hOCT1, (3) Antiviral (Zidovudine): hOAT1, 2, 3, 4, (4) Antitumor dug (Methotrexate): hOAT1, 3, 4, (5) Tetracycline: hOAT1, 2, 3, 4, (6) Mycotoxin (Ochratoxin A): hOAT1, 3, 4, (7) Uremic toxin (Indoxyl sulfate): rat-OAT1, OAT3. In (3), it was predicted that the molecule responsible for the drug interaction between methotrexate and nonsteroidal antiinflammatory drugs is hOAT3. 2. Evaluation of organic anion transport inhibitors: We undertook to predict the target hOATs for betamipron and cilastatin, which are co-administered with carbapenpen antibiotics, and probenecid in vivo. It was predicted that betamipron inhibits hOAT1, 3, cilastatin dose hOAT1, and probenecid dose hOAT4 in vivo. 3. Elucidation of OAT in the induction of drug-induced nephrotoxicity: It was suggested that hOAT1, 3 are associated with the induction of odhratoxin A-induced nephrotoxicity, and rOAT1 and rOAT3 are associated with the induction of indoxyl sulfate-induced nephrotoxicity. The current results provide not only the molecular basis for renal drug transport, but also the information for the safer and more efficient use of drugs.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takeda M., Babu E., Narikawa S., Endou H.: "Interaction of human organic anion transporters with cephalosporin antibiotics"Eur. J. Pharmacol. 438. 137-142 (2002)
Takeda M.、Babu E.、Narikawa S.、Endou H.:“人体有机阴离子转运蛋白与头孢菌素抗生素的相互作用”Eur。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Khamdang S., Takeda M., Narikawa S., Enomoto A., Anzai N., Piyachaturawat P., and Endou H.: "Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflamatory drugs"J. Pharmacol. Exp. Ther. 303. 534-
Khamdang S.、Takeda M.、Narikawa S.、Enomoto A.、Anzai N.、Piyachaturawat P. 和 Endou H.:“人类有机阴离子转运蛋白和人类有机阳离子转运蛋白与非甾体抗炎药的相互作用”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Enomoto A et al.: "Interactionof human organic anion transporter 2 and 4 with organic anion transport inhibitors"Journal of Pharmacology and Experimental Therapeutics. 301. 797-802 (2002)
Enomoto A 等人:“人有机阴离子转运蛋白 2 和 4 与有机阴离子转运抑制剂的相互作用”药理学和实验治疗学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeda M et al.: "Human organic anion transporters and organic cation transporters mediate renal antiviral transport"Journal of Pharmacology and Experimental Therapeutics. (印刷中).
Takeda M等人:“人类有机阴离子转运蛋白和有机阳离子转运蛋白介导肾脏抗病毒转运”药理学和实验治疗学杂志(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeda M et al.: "Characterization of organic anion transport inhibitor using cells stably expressing human organic anion transporters"European Journal of Pharmacology. 419. 113-120 (2001)
Takeda M 等人:“使用稳定表达人有机阴离子转运蛋白的细胞表征有机阴离子转运抑制剂”欧洲药理学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
The elucidation of cephaloridine-induced nephrotoxicity in cell lines stably expressing organic anion transporters
-
批准号:11671048
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:TAKEDA Michio
-
依托单位:
Elucidation of the intracellular mechanisms of cisplatin-induced apoptosis in renal cell line
-
批准号:08671297
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:TAKEDA Michio
-
依托单位:
海外基金